StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report released on Friday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Performance
Shares of Cumberland Pharmaceuticals stock opened at $2.27 on Friday. The firm has a 50 day simple moving average of $1.40 and a 200 day simple moving average of $1.40. Cumberland Pharmaceuticals has a fifty-two week low of $1.04 and a fifty-two week high of $3.05. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.13 and a quick ratio of 0.99. The firm has a market cap of $31.88 million, a P/E ratio of -2.95 and a beta of 0.30.
About Cumberland Pharmaceuticals
Recommended Stories
- Five stocks we like better than Cumberland Pharmaceuticals
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Are Treasury Bonds?
- CarMax Gets in Gear: Is Now the Time to Buy?
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.